6 result(s) displayed (1 - 6 of 6):

Sanofi-Merrimack deal keeps trend alive (from Corporate Dealmaker)

Our oncology M&A list keeps growing. Sanofi-Aventis SA (NYSE:SNY), which is already on it, is acquiring the rights to sell an experimental cancer treatment developed by Merrimack Pharmaceuticals Inc. for up to $530 million. The Deal Pipeline (subscription required) has details on the transaction.The Merrimack deal comes after a setback...

Posted on October 1, 2009 2:06 PM

Sanofi-Aventis takes axe to pipeline, M&A persists (from Corporate Dealmaker)

After about five months on the job, Sanofi-Aventis SA (NYSE:SNY) chief executive Chris Viehbacher is making his presence felt as the company reports profits are up about 16% and confirmed 2009 guidance.Viehbacher, on the hunt for acquisitions, cut 14 drugs in development from its pipeline of 65 -- including four...

Posted on April 29, 2009 2:53 PM

Sanofi's dealmaker gets even more work (from Corporate Dealmaker)

It hasn't even been two weeks since we last looked at what was on the dealmaking plate for Laurence Debroux, the CFO that's now also strategy chief at Sanofi-Aventis SA (NYSE:SNY), and the Paris firm has announced another two deals valued at over $1 billion.The Deal Pipeline shows Sanofi...

Posted on April 15, 2009 3:12 PM

Sleepless in Sanofi (from Corporate Dealmaker)

When CFO Laurence Debroux changed her role to include dealmaking at Sanofi-Aventis SA (NYSE:SNY), she knew her schedule would get pretty busy. A few weeks before Debroux (pictured) became the French pharma giant's chief strategy officer, CEO Chris Viehbacher made it clear the company was seeking acquisitions -- of a...

Posted on April 2, 2009 4:34 PM

Sanofi adds chief strategy officer to aid in transformation (from Corporate Dealmaker)

Sanofi-Aventis SA has created a chief strategy officer position as it looks to reduce its reliance on blockbuster drugs. CFO Laurence Debroux (pictured) will take on the new role and will focus on better coordinating partnerships, M&A and other development projects with corporate strategy. She will report to chief executive...

Posted on February 12, 2009 9:59 AM

Sanofi-Aventis: Another pharma seeking deals (from Corporate Dealmaker)

With cash on their balance sheets, blockbuster drugs headed off-patent and other product gaps that need filling, healthcare giants are on the acquisition trail. Chris Viehbacher, CEO of France's Sanofi-Aventis, said he plans to make acquisitions and wants to diversify the group's product range, according to a Reuters report. Over-the-counter...

Posted on February 2, 2009 1:31 PM